quick one hong kong members reported both clinic and pharmacy routes and a wide price range between the two, happy to be corrected
#asia 2026-06-19
- fibre_first — india has a real generics manufacturing base and a real domestic market. what a specific product is, and whether it matches its label, is a separate question every… 19:29
- slow.taper — right so update from 23 months ago: availability in the region is broadly the same and the prices i track are slightly higher 20:44
- ash_assays — japan being expensive despite the approval is the pattern. approval sets the licence and the pricing system sets the price 21:57
singapore was reported in here at around 400 to 600 singapore dollars a month a year or so ago, prescription only, take that with a pinch of salt
figures are from last year
physical proximity to the manufacturing changed my shipping cost far more than it changed my shipping time
anyone in japan paying out of pocket and what does that look like
follow up japanese insurance covered the diabetes indication and not the weight one as far as anyone here could establish a year ago
anyone shipped from inside the region and had it take longer than from further away
a korean member said their clinic visit took under an hour end to end, which is not a claim about the quality of the assessment
anyone had a parcel stopped moving between two asian countries
getting seen in korea was faster than any route a uk member described at the time we were both describing it
generics being available and generics being right for your situation are different questions, and only one of them is a chat question
write it down for the pharmacy
transit inside the region ran 15 days for me, which was not faster than a longer route with a better carrier
singapore pricing, anyone able to put a number on it
update on the earlier thing singapore customs, is a personal quantity fine
india has a real generics manufacturing base and a real domestic market. what a specific product is, and whether it matches its label, is a separate question every single time
as of about a year ago korea had the shortest path from deciding to starting of anywhere members here had described
whats the position in taiwan or thailand, anyone at all
being closer to the manufacturing does not shorten customs. my parcels from three hours away took as long as ones from europe
closer supplier, fewer flight hours, same number of customs steps. the steps are the slow part
while im here japan approved it for both indications a while ago as i understood it, and the approval did not make it cheap
closer isnt simpler
customs inside asia caught my parcel once in four years. that is my rate, not a regional statistic
nobody here can tell you what will clear customs where you are and that is enforced in this channel, anyway
the indian landscape is qualitatively different from research supply, it is a licensed pharmaceutical industry, and that is still not a guarantee about the vial you received
japan approved it
a parcel of mine was held inside the region and released after 5 days with no letter and no charge
for the archive is anyone here avoiding summer shipping the way the australians do
how do people handle the language side with a local pharmacy
right so update from 23 months ago: availability in the region is broadly the same and the prices i track are slightly higher
*PeptideMeter not the other one
i was wrong about japanese pricing by a factor of two when i quoted it in here, because i was quoting a clinic and somebody else was quoting a pharmacy
follow up a member in hong kong and a member in singapore compared the same dose and came out about forty percent apart
korea is fast
how careful should i be about the claims on an indian generic
anyone compared a japanese pharmacy price against a private clinic in the region
i treat a claim about an indian generic the way i treat any claim about any product. get a lot number and get it tested, ask me again in a month
japan approved it a while back didnt it, what does it cost there
customs between asian countries has not been noticeably easier in anything members have reported. each border is its own border
japan being expensive despite the approval is the pattern. approval sets the licence and the pricing system sets the price
get it tested anyway
diabetes indication only